Latocha Małgorzata, Zięba Andrzej, Polaniak Renata, Kuśmierz Dariusz, Nowosad Ada, Jurzak Magdalena, Romuk Ewa, Kokocińska Mirosława, Sliupkas-Dyrda Elektra
Acta Pol Pharm. 2015 Sep-Oct;72(5):909-15.
Cancer therapy is challenging for scientists because of low effectiveness of so far existing therapies (especially in case of great invasiveness and advanced tumor stage). Such need for new drug development and search for more efficient new findings in therapeutical applications is therefore still valid. There are also conducted studies on modifying so far existing drugs and their new methods of usage in oncology practice. One of them is phenothiazine and its derivatives which are used in psychiatric treatment for years. They also exhibit antiprion, antiviral, antibacterial and antiprotozoal properties. Cytotoxic activity, influence on proliferation, ability to induce apoptosis suggest also a possibility of phenothiazine derivatives usage in cancer cells termination. The aim of our the study was to evaluate the influence of two amine derivatives of phenothiazine on cancer cells in vitro. Amelanotic melanoma C-32 cell line (ATCC) and glioma SNB-19 cells (DSMZ) were used in this study and two derivatives were analyzed. In view of examined substances tumor potential toxicity cells proliferation and viability exposed to phenothiazine derivatives were established. Cell cycle regulatory genes expression (TP53 and CDKN1A), S-phase marker--H3 gene and intracellular apoptosis pathway genes (BAX, BCL-2) were analyzed using RT-QPCR method. The influence of examined derivatives on total cell oxidative status (TOS), total antioxidative status (TAS), malondialdehyde concentration (MDA) and superoxide dismutase activity (SOD) were analyzed. As a result, examined phenothiazine derivatives cytotoxic action on C-32 and SNB-19 and also cells proliferation inhibition were determined. Cell cycle regulatory genes (TP53, CDKN1A) expression and protein products of genes involved in mitochondial apoptosis pathway (BAX, BCL-2) expression are changed by the presence of phenothiazine derivatives during culturing. There were also noted small changes in redox potential in cells exposed to two mentioned phenothiazine derivatives.
癌症治疗对科学家来说具有挑战性,因为目前现有疗法的有效性较低(尤其是在侵袭性强和肿瘤晚期的情况下)。因此,对新药开发以及在治疗应用中寻找更有效新发现的需求仍然存在。此外,也在进行关于改进现有药物及其在肿瘤学实践中的新用法的研究。其中之一是吩噻嗪及其衍生物,它们已在精神治疗中使用多年。它们还具有抗朊病毒、抗病毒、抗菌和抗原虫特性。细胞毒性活性、对增殖的影响以及诱导凋亡的能力也表明吩噻嗪衍生物有可能用于癌细胞的消除。我们研究的目的是评估吩噻嗪的两种胺衍生物对体外癌细胞的影响。本研究使用了无黑色素黑色素瘤C - 32细胞系(美国典型培养物保藏中心)和神经胶质瘤SNB - 19细胞(德国微生物和细胞培养物保藏中心),并分析了两种衍生物。鉴于所检测物质,确定了暴露于吩噻嗪衍生物的肿瘤潜在毒性、细胞增殖和活力。使用逆转录定量聚合酶链反应(RT - QPCR)方法分析细胞周期调控基因(TP53和CDKN1A)、S期标志物——H3基因以及细胞内凋亡途径基因(BAX、BCL - 2)的表达。分析了所检测衍生物对总细胞氧化状态(TOS)、总抗氧化状态(TAS)、丙二醛浓度(MDA)和超氧化物歧化酶活性(SOD)的影响。结果,确定了所检测的吩噻嗪衍生物对C - 32和SNB - 19细胞的细胞毒性作用以及对细胞增殖的抑制作用。在培养过程中,吩噻嗪衍生物的存在改变了细胞周期调控基因(TP53、CDKN1A)的表达以及参与线粒体凋亡途径的基因(BAX、BCL - 2)的蛋白质产物的表达。还注意到暴露于上述两种吩噻嗪衍生物的细胞中氧化还原电位有微小变化。